Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Vitamins and Hormones|February 11, 2000
HIV protease: enzyme function and drug resistanceS Gulnik, J W Erickson, D XieJournal of Molecular Biology|September 5, 1992
Human liver cathepsin D. Purification, crystallization and preliminary X-ray diffraction analysis of a lysosomal enzymeS Gulnik, E T Baldwin, N Tarasova, et al.Protein Science : a Publication of the Protein Society|December 14, 1999
Real-time measurements of dark substrate catalysisD Xie, L Suvorov, J W Erickson, et al.Virology|November 14, 1998
Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cellsR H Stauber, E Afonina, S Gulnik, et al.Biochemistry|January 24, 1998
Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residuesD Xie, S Gulnik, L Collins, et al.Protein Science : a Publication of the Protein Society|August 19, 1999
Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pHD Xie, S Gulnik, E Gustchina, et al.FEBS Letters|May 20, 2000
A novel putative transcription factor protein MYT2 that preferentially binds supercoiled DNA and induces DNA synthesis in quiescent cellsW Shao, A Y Lee, S Gulnik, et al.AIDS (London, England)|December 22, 1999
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapyM Nijhuis, R Schuurman, D de Jong, et al.Antimicrobial Agents and Chemotherapy|April 1, 1993
In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatineS Kageyama, T Mimoto, Y Murakawa, et al.Structure (London, England : 1993)|June 15, 1995
Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatineE T Baldwin, T N Bhat, S Gulnik, et al.Pageof 2